| 18.04.2024 14:17 | WPP, SMWH, ZIN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 16.04.2024 09:48 | CWR, BHP, PDL | LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group | Alliance |
| 16.04.2024 08:39 | AZN | AstraZeneca's hails Imfinzi survival data on cancer form | Alliance |
| 11.04.2024 17:30 | AZN | Result of AGM | RNS |
| 11.04.2024 08:56 | AZN | TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023 | Alliance |
| 11.04.2024 07:00 | AZN | AstraZeneca increases 2024 dividend by 7% | RNS |
| 08.04.2024 08:36 | AZN | TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris | Alliance |
| 08.04.2024 07:00 | AZN | Enhertu approved in US for HER2+ solid tumours | RNS |
| 08.04.2024 06:53 | AZN | TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval | Alliance |
| 05.04.2024 09:42 | AZN | AstraZeneca makes "breakthrough" in treating small cell lung cancer | Alliance |
| 05.04.2024 07:00 | AZN | Imfinzi improved OS & PFS in limited-stage SCLC | RNS |
| 04.04.2024 13:09 | AZN | UK shareholder meetings calendar - next 7 days | Alliance |
| 03.04.2024 11:02 | AZN | CORRECT: AstraZeneca, Daiichi make US progress with licence approvals | Alliance |
| 02.04.2024 15:00 | AZN | Total Voting Rights | RNS |
| 02.04.2024 10:25 | AZN | AstraZeneca and Daiichi make US progress with latest licence approvals | Alliance |
| 02.04.2024 09:54 | CCH, DPLM, SYNT | LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform' | Alliance |
| 02.04.2024 07:05 | AZN | Voydeya approved in US | RNS |
| 02.04.2024 07:00 | AZN | FDA accepts Dato-DXd BLA for breast cancer | RNS |
| 27.03.2024 11:56 | AZN, INDV, C4XD | C4X Discovery seeks AIM delisting but half-year revenue skyrockets | Alliance |
| 27.03.2024 09:19 | AZN | AstraZeneca treatments become "first and only" to be approved in Japan | Alliance |
| 25.03.2024 08:40 | AZN | TOP NEWS: AstraZeneca wins US approval for rare nervous system disease | Alliance |
| 25.03.2024 07:00 | AZN | Ultomiris approved in the US for NMOSD | RNS |
| 21.03.2024 16:43 | AZN | AstraZeneca's Tagrisso successful in treating lung cancer | Alliance |
| 19.03.2024 08:56 | AZN | TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion | Alliance |
| 19.03.2024 07:00 | AZN | AstraZeneca to acquire Fusion | RNS |
| 18.03.2024 16:09 | SHEL, MTVW, EDV | UK dividends calendar - next 7 days | Alliance |
| 18.03.2024 14:08 | AZN | AstraZenca hails Imfinzi and Lynparza results on endometrial cancer | Alliance |
| 14.03.2024 10:01 | AZN | TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion | Alliance |
| 14.03.2024 07:00 | AZN | AstraZeneca to acquire Amolyt | RNS |
| 12.03.2024 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 08.03.2024 06:00 | AZN | Astra, Sanofi's antibody 90% effective against RSV in infants - CDC | Alliance |
| 07.03.2024 11:00 | AZN | Notice of AGM | RNS |
| 06.03.2024 15:05 | AZN | Director/PDMR Shareholding | RNS |
| 06.03.2024 15:00 | AZN | Director/PDMR Shareholding | RNS |
| 06.03.2024 14:40 | AZN, NWG | UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted | Alliance |
| 05.03.2024 14:24 | AZN | AstraZeneca's breast cancer treatment blocked for NHS use in England | Alliance |
| 04.03.2024 09:31 | AZN | AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment | Alliance |
| 04.03.2024 07:00 | AZN | EMA validates Dato-DXd MAAs for NSQ NSCLC and BC | RNS |
| 01.03.2024 15:00 | AZN | Total Voting Rights | RNS |
| 26.02.2024 08:51 | AZN | AstraZeneca's Voydeya treatment recommended for EU approval | Alliance |
| 26.02.2024 07:00 | AZN | Voydeya recommended for EU approval | RNS |
| 22.02.2024 17:36 | OMI, FARN, AMIF | EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track" | Alliance |
| 22.02.2024 13:15 | AZN | Acquisition of Gracell completed | RNS |
| 22.02.2024 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 22.02.2024 07:00 | AZN | AstraZeneca prices a $5bn bond offering | RNS |
| 21.02.2024 07:00 | AZN | Filing of Form 20-F with SEC | RNS |
| 20.02.2024 11:00 | AZN | Annual Financial Report | RNS |
| 20.02.2024 09:40 | XPP, EMG, HBR | LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28% | Alliance |
| 19.02.2024 15:39 | AZN | UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax | Alliance |
| 19.02.2024 15:00 | AZN | AstraZeneca completes acquisition of Icosavax | RNS |
| 19.02.2024 08:36 | AZN | TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data | Alliance |
| 19.02.2024 07:10 | AZN | Tagrisso plus chemo approved in US for lung cancer | RNS |
| 19.02.2024 07:05 | AZN | FDA accepts Dato-DXd BLA for nonsquamous NSCLC | RNS |
| 19.02.2024 07:00 | AZN | Tagrisso improved PFS in Stage III lung cancer | RNS |
| 15.02.2024 14:44 | BRCK, WTAN, VMUK | UK dividends calendar - next 7 days | Alliance |
| 13.02.2024 09:32 | ITM, XPS, PHP | LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions | Alliance |
| 12.02.2024 09:41 | GNC, JET, ROO | LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy' | Alliance |
| 09.02.2024 09:15 | GSK, SSE, AZN | LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell' | Alliance |
| 08.02.2024 08:44 | AZN | TOP NEWS: AstraZeneca confident after 2023 profit more than doubles | Alliance |
| 08.02.2024 07:00 | AZN | Final Results | RNS |
| 02.02.2024 08:38 | AZN | AstraZeneca celebrates latest successful trial of acoramidis in Japan | Alliance |
| 02.02.2024 06:22 | AZN | TOP NEWS: US sends drugmakers initial offers in Medicare price talks | Alliance |
| 01.02.2024 15:52 | ULVR, SSE, RDW | UK earnings, trading statements calendar - next 7 days | Alliance |
| 29.01.2024 08:19 | AZN | TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US | Alliance |
| 19.01.2024 09:28 | AZN | TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH | Alliance |
| 16.01.2024 09:14 | BDEV, BKG, BARC | LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca | Alliance |
| 03.01.2024 10:16 | AZN, NFX | IN BRIEF: Nuformix narrows annual loss as develops drug assets | Alliance |
| 03.01.2024 10:12 | AZN, MKA, GTC | AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals | Alliance |
| 03.01.2024 09:23 | GNC, ROO, CWK | LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold' | Alliance |
| 03.01.2024 08:04 | AZN, C4XD | C4X receives USD11 million from AstraZeneca following NRF2 trials | Alliance |
| 02.01.2024 15:00 | AZN | Total Voting Rights | RNS |
| 02.01.2024 08:26 | AZN | AstraZeneca and Sanofi received approval in China for RSV antibody | Alliance |
| 27.12.2023 08:24 | AZN | TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline | Alliance |
| 27.12.2023 07:00 | AZN | AstraZeneca acquires Gracell | RNS |
| 22.12.2023 08:47 | AZN | AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone" | Alliance |
